Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L M Burrell

Showing results (11-20 of 88) with videos related to

Pageof 9
Sort By:
Internal Medicine Journal|October 11, 2012
Angiotensin-converting enzyme 2 polymorphisms and cardiovascular riskJ A Grace, L M Burrell, S K Patel
Scandinavian Journal of Clinical and Laboratory Investigation|December 1, 1991
Is the fluorescein dilaurate test suitable for monitoring the effectiveness of pancreatic enzyme replacement therapy?L M Burrell, E J Boyd, K G Wormsley
Clinical Endocrinology|September 1, 1991
The effect of drinking on atrial natriuretic peptide, vasopressin and thirst appreciation in hyperosmolar manL M Burrell, H J Lambert, P H Baylis
The American Journal of Physiology|March 10, 1999
Vasopressin V2 receptor enhances gain of baroreflex in conscious spontaneously hypertensive ratsD B Sampey, L M Burrell, R E Widdop
Journal of Hypertension|June 29, 2000
Reversal of cardiac hypertrophy and fibrosis by S21402, a dual inhibitor of neutral endopeptidase and angiotensin converting enzyme in SHRsN K Farina, C I Johnston, L M Burrell
The American Journal of Physiology|March 1, 1991
Effect of atrial natriuretic peptide on thirst and arginine vasopressin release in humansL M Burrell, H J Lambert, P H Baylis
Clinical Science (London, England : 1979)|July 1, 1992
Atrial natriuretic peptide inhibits fluid intake in hyperosmolar subjectsL M Burrell, J M Palmer, P H Baylis
European Journal of Pharmacology|October 21, 1999
In vivo and in vitro characterisation of a nonpeptide vasopressin V(1A) and V(2) receptor antagonist (YM087) in the ratJ Risvanis, M Naitoh, C I Johnston, et al.
British Journal of Obstetrics and Gynaecology|April 1, 1990
Autoimmune ovarian failure with elevated serum levels of luteinizing hormone and enlarged ovaries. Case reportL M Burrell, A Murdoch, B Angus, et al.
Journal of Occupational and Environmental Medicine|June 24, 1998
Occupational upper extremity disorders in the federal workforce. Prevalence, health care expenditures, and patterns of work disabilityM Feuerstein, V L Miller, L M Burrell, et al.
Pageof 9

Showing results (11-20 of 88) with videos related to

Sort By:
Pageof 9
Internal Medicine Journal|October 11, 2012
Angiotensin-converting enzyme 2 polymorphisms and cardiovascular riskJ A Grace, L M Burrell, S K Patel
Scandinavian Journal of Clinical and Laboratory Investigation|December 1, 1991
Is the fluorescein dilaurate test suitable for monitoring the effectiveness of pancreatic enzyme replacement therapy?L M Burrell, E J Boyd, K G Wormsley
Clinical Endocrinology|September 1, 1991
The effect of drinking on atrial natriuretic peptide, vasopressin and thirst appreciation in hyperosmolar manL M Burrell, H J Lambert, P H Baylis
The American Journal of Physiology|March 10, 1999
Vasopressin V2 receptor enhances gain of baroreflex in conscious spontaneously hypertensive ratsD B Sampey, L M Burrell, R E Widdop
Journal of Hypertension|June 29, 2000
Reversal of cardiac hypertrophy and fibrosis by S21402, a dual inhibitor of neutral endopeptidase and angiotensin converting enzyme in SHRsN K Farina, C I Johnston, L M Burrell
The American Journal of Physiology|March 1, 1991
Effect of atrial natriuretic peptide on thirst and arginine vasopressin release in humansL M Burrell, H J Lambert, P H Baylis
Clinical Science (London, England : 1979)|July 1, 1992
Atrial natriuretic peptide inhibits fluid intake in hyperosmolar subjectsL M Burrell, J M Palmer, P H Baylis
European Journal of Pharmacology|October 21, 1999
In vivo and in vitro characterisation of a nonpeptide vasopressin V(1A) and V(2) receptor antagonist (YM087) in the ratJ Risvanis, M Naitoh, C I Johnston, et al.
British Journal of Obstetrics and Gynaecology|April 1, 1990
Autoimmune ovarian failure with elevated serum levels of luteinizing hormone and enlarged ovaries. Case reportL M Burrell, A Murdoch, B Angus, et al.
Journal of Occupational and Environmental Medicine|June 24, 1998
Occupational upper extremity disorders in the federal workforce. Prevalence, health care expenditures, and patterns of work disabilityM Feuerstein, V L Miller, L M Burrell, et al.
Pageof 9